Abvc Biopharma Stock Market Value
| ABVC Stock | USD 0.53 0.02 3.92% |
| Symbol | ABVC |
ABVC Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share 0.017 | Quarterly Revenue Growth 18.175 | Return On Assets (0.45) | Return On Equity (3.20) |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ABVC Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ABVC Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ABVC Biopharma.
| 06/09/2023 |
| 11/30/2024 |
If you would invest 0.00 in ABVC Biopharma on June 9, 2023 and sell it all today you would earn a total of 0.00 from holding ABVC Biopharma or generate 0.0% return on investment in ABVC Biopharma over 540 days. ABVC Biopharma is related to or competes with Indaptus Therapeutics, Pasithea Therapeutics, Forte Biosciences, Aileron Therapeutics, Akari Therapeutics, Aditxt, and RenovoRx. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet me... More
ABVC Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ABVC Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ABVC Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 35.84 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 7.25 |
ABVC Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABVC Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ABVC Biopharma's standard deviation. In reality, there are many statistical measures that can use ABVC Biopharma historical prices to predict the future ABVC Biopharma's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (1.22) | |||
| Treynor Ratio | 0.3647 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABVC Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ABVC Biopharma Backtested Returns
ABVC Biopharma secures Sharpe Ratio (or Efficiency) of -0.0313, which signifies that the company had a -0.0313% return per unit of volatility over the last 3 months. ABVC Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABVC Biopharma's Variance of 33.36, mean deviation of 3.76, and Market Risk Adjusted Performance of 0.3747 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ABVC Biopharma are expected to decrease at a much lower rate. During the bear market, ABVC Biopharma is likely to outperform the market. At this point, ABVC Biopharma has a negative expected return of -0.18%. Please make sure to confirm ABVC Biopharma's potential upside and the relationship between the accumulation distribution and period momentum indicator , to decide if ABVC Biopharma performance from the past will be repeated in the future.
Auto-correlation | 0.75 |
Good predictability
ABVC Biopharma has good predictability. Overlapping area represents the amount of predictability between ABVC Biopharma time series from 9th of June 2023 to 5th of March 2024 and 5th of March 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ABVC Biopharma price movement. The serial correlation of 0.75 indicates that around 75.0% of current ABVC Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
ABVC Biopharma lagged returns against current returns
Autocorrelation, which is ABVC Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ABVC Biopharma's stock expected returns. We can calculate the autocorrelation of ABVC Biopharma returns to help us make a trade decision. For example, suppose you find that ABVC Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ABVC Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ABVC Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ABVC Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ABVC Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
ABVC Biopharma Lagged Returns
When evaluating ABVC Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ABVC Biopharma stock have on its future price. ABVC Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ABVC Biopharma autocorrelation shows the relationship between ABVC Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in ABVC Biopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:Check out ABVC Biopharma Correlation, ABVC Biopharma Volatility and ABVC Biopharma Alpha and Beta module to complement your research on ABVC Biopharma. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.